OlickR. S., Taking Advance Directives Seriously: Prospective Autonomy and Decisions Near the End of Life (Washington, D.C.: Georgetown University Press, 2001); GastmansC.De LepeleireJ., “Living to the Bitter End? A Personalist Approach to Euthanasia in Persons with Severe Dementia,”Bioethics24, no. 2 (2010): 78–86; KellehearA., “Dying as a Social Relationship: A Sociological Review of Debates on the Determination of Death,”Social Science & Medicine66 (2008): 1533–1544.
2.
SassH. M.VeatchR. M.KimuraR., eds., Advance Directives and Surrogate Decision Making in Health Care: United States, Germany, and Japan (Baltimore: Johns Hopkins University Press, 1998); SchicktanzS.RazA.ShalevC., “The Cultural Context of End-of-Life Ethics: A Comparison of Germany and Israel,”Cambridge Quarterly of Healthcare Ethics19 (2010): 381–94; SprungC. L.MaiaP.BulowH.-H., “The Importance of Religious Affiliation and Culture on End-of-Life Decisions in European Intensive Care Units,”Intensive Care Medicine33, no. 10 (2007): 1732–1739.
3.
American Academy of Family Physicians, “Definition of Hospice,”2003, available at <www.aafp.org/X6864.xml>.
4.
DunnH., Hard Choices for Loving People, 5th ed. (Lansdowne, VA: A&A Publishers, 2009).
5.
BeširevicV., “End-of-Life Care in the 21st Century: Advance Directives in Universal Rights Discourse,”Bioethics24, no. 3 (2010): 105–111; MatthijsP. S.WijmenV.RurupM. L., “Advance Directives in The Netherlands: An Empirical Contribution to the Exploration of a Cross-Cultural Perspective on Advance Directives,”Bioethics24, no. 3 (2010): 118–126.
6.
International Bioethics Committee (IBC), Report of the IBC on the Possibility of Elaborating a Universal Instrument on Bioethics, Paris, 2003.
7.
BennettC. J., “What Is Policy Convergence and What Causes It?”British Journal of Political Science21, no. 2 (1991): 215–233.
8.
ChernichovskyD., “Health System Reforms in Industrialized Democracies: An Emerging Paradigm,”Milbank Quarterly73, no.3 (1995): 339–356; FieldM. G., “Comparative Health Systems and the Convergence Hypothesis: The Dialectics of Universalism and Particularism,” in PowellF. D.WessenA. F., eds., Health Care Systems in Transition: An International Perspective (Thousand Oaks, CA: Sage, 1999).
9.
HarrisonS.MoranM.WoodB., “Policy Emergence and Policy Convergence: The Case of ‘Scientific-Bureaucratic Medicine’ in the United States and United Kingdom,”British Journal of Politics and International Relations4, no. 1 (2002): 1–24.
10.
PollittC., “Clarifying Convergence: Striking Similarities and Durable Differences in Public Management Reform,”Public Management Review4, no. 1 (2002): 471–492.
11.
BlankR. H.BurauV., Comparative Health Policy, 3rd ed. (Basingstoke: Palgrave, 2010).
12.
MacerD., ed., Eubios Journal of Asian and International Bioethics, published by Eubios Ethics Institute, Christchurch, New Zealand.
13.
CoxC. L.ColeE.ReynoldsT.WandragM., “Implications of Cultural Diversity in Do Not Attempt Resuscitation (DNAR) Decisions,”Journal of Multicultural Nursing & Health12, no. 1 (2006): 20–28.
14.
JusticeC., “The Natural Death While Not Eating: A Type of Palliative Care in Banaras, India,”Journal of Palliative Care11, no. 1 (1995): 38–42.
15.
ChattopadhyayS.SimonA., “East Meets West: Cross-Cultural Perspective in End-of-Life Decision Making from Indian and German Viewpoints,”Medicine, Health Care and Philosophy11 (2008): 165–174, at 165.
16.
Id.
17.
CroasdaleM., “Study Examines Death across Cultures,”American Medical News48, no. 31 (2005): 13.
18.
See Schicktanz, supra note 2.
19.
MatthijsP. S.WijmenV.RurupM. L.RoelineH.PasmanW.KaspersP. J.Onwuteaka-PhilipsenB. D., “Advance Directives in The Netherlands: An Empirical Contribution to the Exploration of a Cross-Cultural Perspective on Advance Directives,”Bioethics24, no. 3 (2010): 118–126.
20.
SearightH. R.GaffordJ., “Cultural Diversity at the End of Life: Issues and Guidelines for Family Physicians,”American Family Physician71, no. 3 (2005): 515–522, at 515.
21.
KelleyA. S.WengerN. S.SarkisianC. A., “Opiniones: End-of-Life Care Preferences and Planning of Older Latinos,”Journal of the American Geriatrics Society58, no. 6 (2010): 1109–1116.
22.
KrelingB.SelskyC.Perret-GentilM.HuertaE. E.MandelblattJ. S., “The Worst Thing about Hospice Is That They Talk About Death: Contrasting Hospice Decisions and Experience among Immigrant Central and South American Latinos with US-Born White, Non-Latino Cancer Caregivers,”Palliative Medicine24, no. 4 (2010): 427–434. Also see, HeymanJ. C.GutheilI. A., “Older Latinos' Attitudes toward and Comfort with End-of-Life Planning,”Health & Social Work35, no. 1 (2010): 17–25.
23.
See SearightGafford, supra note 20, at 517.
24.
Id., at 518.
25.
HuW. Y.ChiuT. Y.ChuangR. B.ChenC. Y., “Solving Family-Related Barriers to Truthfulness in Cases of Terminal Cancer in Taiwan: A Professional Perspective,”Cancer Nursing25, no. 6 (2002): 486–492.
26.
TangS. T.LiuT. W.LaiM. S.LiuL. N.ChenC. H., “Concordance of Preferences for End-of-Life Care between Terminally Ill Cancer Patients and Their Family Caregivers in Taiwan,”Journal of Pain Symptom Management30 (2005): 510–518.
27.
GanzF. D.BenbenishtyJ.HerschM.FischerA.GurmanG.SprungC. L., “The Impact of Regional Culture on Intensive Care End of Life Decision Making: An Israeli Perspective from The ETHICUS Study,”Journal of Medical Ethics32 (2006): 196–199. See also CohenS.SprungC.SjokvistP.LippertA., 'Communication of End-of-Life Decisions in European Intensive Care Units,” Intensive Care Medicine31, no. 9 (2005): 1215–1221.
28.
SprungC. L.MaiaP.BulowH-H.RicouB., “The Importance of Religious Affiliation and Culture on End-of-Life Decisions in European Intensive Care Units,”Intensive Care Medicine33, no. 10 (2007): 1732–1739.
29.
BergerJ. T., “Culture and Ethnicity in Clinical Care,”Archives of Internal Medicine158 (1998): 2085–2090; ThomasN. D., “The Importance of Culture throughout all of Life and Beyond,”Holistic Nursing Practice15 (2001): 40–46; SealeC., “Characteristics of End-of-Life Decisions: Survey of UK Medical Practitioners,”Palliative Medicine20 (2006): 653–659; WiedermannC. J.DrumlC., “End-of-life Decisions in Austria's Intensive Care Units,”Intensive Care Medicine34, no. 6 (2008): 1142–1144; YaguchiA.TruogR. D.CurtissJ. R.LuceJ. M.LevyM. M.MelotC.VincentV. L., “International Differences in End-of-Life Attitudes in the Intensive Care Unit,”Archives of Internal Medicine165 (2005): 1970–1975.
30.
See SearightGafford, supra note 20.
31.
See Berger, supra note 29; BertoliniG.BoffelliS.MalacarneP., “End-of-Life Decision-Making and Quality of ICU Performance: An Observational Study in 84 Italian Units,”Intensive Care Medicine36, no. 9 (2010): 1495–1504; ServilloG.StrianoP., “End-of-Life: Still an Italian Dilemma,”Intensive Care Medicine34, no. 7 (2008): 1333–1335.
32.
ShrankW. H.KutnerJ. S.RichardsonT., “Focus Group Findings about the Influences of Communication Preferences in End-of-Life Care,”Journal of General Internal Medicine20, no. 8 (2005): 703–709.
33.
TurnerL., “Medical Ethics in a Multicultural Society,”Journal of the Royal Society of Medicine94 (2001): 592–594; TurnerL., “Bioethics in Pluralistic Societies,”Medicine, Health Care and Philosophy7 (2004): 201–208.
34.
BlankR. H.MerrickJ., eds., End-of-Life Decision Making: A Cross-National Study (Cambridge: MIT Press, 2005). Although the data from this study are six years old, where possible I contacted the authors of the chapters (and searched the literature for other evidence) to ascertain if there have been any major changes in their countries that would alter their original conclusions. With only a few exceptions, which are raised in the discussion below, the description of these countries remains accurate.
35.
AloraA. T.LumitaoJ. M., Beyond Western Bioethics: Voices from the Developing World (Washington, D.C.: Georgetown University Press, 2001).
36.
PessiniL., “Ethical Questions Related to End of Life Decisions: The Brazilian Reality,” in BlankMerrick, eds., supra note 34, at 13–32.
37.
WasunnaA., “End of Life Decision Making in Kenya,” in BlankMerrick, eds., supra note 34, at 131–46.
38.
LiY.DoeringO.FangL.LiF.BaoqiS., “End of Life Decision Making in China: A View from Beijing,” in BlankMerrick, eds., supra note 34, at 33–60.
39.
AmidrorT.LeavittF. J., “End of Life Decision Making in Israel,” in BlankMerrick, eds., supra note 34, at 97–108.
40.
AshcroftR., “Death Policy in the United Kingdom,” in BlankMerrick, eds., supra note 34, at 197–218.
41.
AksoyS., “End of Life Decision Making in Turkey,” in BlankMerrick, eds., supra note 34, at 183–96.
42.
See Wasunna, supra note 37.
43.
PandyaS. K., “End of Life Decision Making in India,” in BlankMerrick, eds., supra note 34, at 79–96; ManiR. K., “End-of-Life Care in India,”Intensive Care Medicine32, no. 4 (2006): 1066–1068.
44.
See Li, supra note 38.
45.
TangS. T., “Meanings of Dying at Home for Chinese Patients in Taiwan with Terminal Cancer: A Literature Review,”Cancer Nursing23 (2000): 367–370; ChiuT.-Y., “End of Life Decision Making in Taiwan,” in BlankMerrick, eds., supra note 34, at 169–82.
46.
SimonA., “End of Life Decision Making in Germany,” in BlankMerrick, eds., supra note 34, at 61–78.
47.
MacerD., “End of Life Care in Japan,” in BlankMerrick, eds., supra note 34, at 109–130.
48.
Dartmouth Institute for Health Policy and Clinical Practice, Quality of End-of-Life Cancer Care for Medicare Beneficiaries (Hanover, NH: Center for Health Policy Research, 2010).
49.
See Ashcroft, supra note 40.
50.
See Pessini, supra note 36.
51.
See Chui, supra note 45.
52.
GlassA. P.ChenL. K.HwangE.OnoY.NahapetyanL., “A Cross-Cultural Comparison of Hospice Development in Japan, South Korea, and Taiwan,”Journal of Cross Cultural Gerontology25, no. 1 (2010): 1–19.
53.
See Aksoy, supra note 41.
54.
See Wasunna, supra note 37.
55.
See Pandya, supra note 43.
56.
See Simon, supra note 46.
57.
ten HaveH., “End of Life Decision Making in Netherlands,” in in BlankMerrick, eds., supra note 34, at 147–68. Also see VincentJ.-L., “End-of-Life Practice in Belgium and the New Euthanasia Law,”Intensive Care Medicine32, no. 11 (2006): 1908–1911.
58.
See Macer, supra note 47.
59.
MerrickJ., “Death and Dying: The American Experience,” in BlankMerrick, eds., supra note 34, at 219–242.
60.
See Chui, supra note 45.
61.
HuangC. H.HuW. Y.ChiuT. Y.ChenC. Y., “The Practicalities of Terminally Ill Patients Signing Their Own DNR Orders: A Study in Taiwan,”Journal of Medical Ethics34 (2008): 336–340.
62.
See Wasunna, supra note 37.
63.
See Aksoy, supra note 41.
64.
See AmidrorLeavitt, supra note 39.
65.
See Macer, supra note 47.
66.
See Pessini, supra note 36.
67.
See Chui, supra note 45.
68.
See Simon, supra note 46.
69.
See Ashcroft, supra note 40.
70.
See Merrick, supra note 48.
71.
SteinbrookR., “Physician-Assisted Death: From Oregon to Washington State,”New England Journal of Medicine359 (2008): 2513–2515.
72.
See ten Have, supra note 57.
73.
See Wasunna, supra note 37.
74.
See AmidorLeavitt, supra note 39.
75.
See Macer, supra note 47.
76.
See Pessini, supra note 36.
77.
See ChattopadhyaySimon, supra note 15.
78.
See BlankR. H., Biomedical Policy (Chicago: Nelson-Hall, 1995): at 163.